Thelansis

  Cervical cancer is outside the pelvis, are classified as persistent/recurrent, metastatic cervical cancer patients. 13% of cervical cancer patients are diagnosed at advanced stages. The 5-year survival rate for metastatic cervical cancer is 16.5%, compared to 91.5% for localized cervical cancer. Cervical cancer is one of the most common malignancies in the female genital tract system. It is the second leading cause of cancer mortality in women aged 20 to 39 years. The prognosis of cervical cancer patients remains poor, especially in metastatic patients. Previous studies have shown that the median survival time of metastatic cervical cancer is only 8-13 months. Due to the poor prognosis, metastatic cervical cancer has become one of the main challenges in the world.   The metastatic and recurrent Cervical cancer Single-site metastasis accounted for 68.7%, and multi-organ metastases were relatively rare. Lung metastasis was the most common in single-site metastasis, account...